Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.


  1. Advanced Patent Search
Publication numberUS3568214 A
Publication typeGrant
Publication dateMar 9, 1971
Filing dateJul 24, 1968
Priority dateJul 24, 1968
Publication numberUS 3568214 A, US 3568214A, US-A-3568214, US3568214 A, US3568214A
InventorsGoldschmied Fabio R
Original AssigneeUniv Utah
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Artificial heart system and method of pumping blood by electromagnetically pulsed fluid
US 3568214 A
Abstract  available in
Previous page
Next page
Claims  available in
Description  (OCR text may contain errors)

Mardl 1 971 F. R. GOLDSCHMIED 3,

ARTIFICIAL HEART SYSTEM AND METHOD OF PUMPING BLOOD BY. ELECTROMAGNETICALLY PULSED FLUID- Filed July '24, 1968 2 Sheets-Sheet l o 35 1 It HI 'I'I a 1 low I I 1 MIM INVENTOR. FABIO R. GOLDSCHMIED ATTORN M rch 9. 1 71 F. R. GOLDSCHMIED 3,553,214 I ARTIFICIAL HEART SYSTEM AND METHOD OF PUMPING BLOOD BY ELECTROMAGNETICALLY PULSED FLUID '2 Sheets-Sheet 2 Filed July 24, 1968 INVENTOR. FABIO R. GOLDSCHMIED ATTORNEY United States Patent 3,568,214 ARTIFICIAL HEART SYSTEM AND METHOD OF PUMPING BLUOD BY ELECTROMAG- NETI'CALLY PULSED FLUID Fabio R. Goldschmied, Salt Lake City, Utah, assignor to University of Utah Filed July 24, 1968, Ser. No. 747,394 Int. Cl. A61f 1/24 US. Cl. 3-1 8 Claims ABSTRACT OF THE DISCLOSURE An artificial heart system including method and apparatus, the apparatus comprising, preferably, two interconnected ventricles, each internally provided with an accumulator diaphragm which is, according to the method, serially flexed in response to pulsatile displacement of electrically conductive fluid other than blood, the displacement being developed by an electromagnetic fluid driving device powered by thermoelectrically derived electrical energy.

The present invention relates to electromagnetic pumping systems and more particularly to electromagnetic pumping systems cooperating with ventricular structure for replacing or assisting a heart in its function of pumping blood through a living body.

In recent years considerable experimentation has been conducted to construct workable artificial heart pumps for replacing or assisting damaged or diseased hearts of living beings. Transplants of artificial hearts in animals have met with limited success, however, a self-contained, fully successful arificial heart has not, until this present invention, been devised.

Pumping devices utilizing moving parts have generated undesirable heat and have been susceptible to wear and deterioration. Electromagnetic pumps, with no mechanical moving parts, have not previously been generally accepted because the use thereof has depended largely upon passing electric current through the blood. See US. Pat. 3,206,768 in this regard. The passing of current through the blood generates undesirable amounts of heat within the blood because of the poor conductivity of the blood. Moreover, the low conductivity of the blood requires the use of high current densities which cause electrolysis of the blood. Difliculty has also occurred in developing suitable power sources which may be implanted within the body for long-term use without servicing or recharging. Many conventional artificial heart devices are powered by external sources of energy, such as compressed air, which greatly restrict the mobility of the user.

It is, therefore, a primary object of the present invention to provide an artificial heart system which alleviates or overcomes problems of the mentioned type.

The present invention utilizes an electromagnetic pump with no moving parts to pulse a conducting fluid other than blood. Preferably, the fluid is in simultaneous communication with two ventricles and is displaced by the electromagnetic pump alternately toward one or the other of the two ventricles. Volume changes in the ventricles are accommodated by flexing diaphragms or accumulators which control the volume of blood allowed within each ventricle and maintain a constant uniform blood volume in a natural body circulatory system. A long-life radioisotope thermoelectric power source adapted to be implanted within the chest cavit is used to supply energy to the electromagnetic pump.

Using the presently preferred apparatus and method of the invention, desirable pulsatile flow is achieved with complete compensation for blood volume changes. Un-

desirable heat and wear of moving mechanical parts is Patented Mar. 9, 1971 eliminated. The problem of electrolysis and heat absorption in the blood are absent and complete mobility of the user is possible for long periods of time.

Accordingly, it is another primary object of the present invention to utilize an electrically conductive and heat conductive fluid, other than blood, for electromagnetic pumping in an improved artificial heart system.

It is another important object of the present invention to provide a novel system for pulsatilely pumping blood using an electromagnetic pumping device Without moving parts.

Another and no less important object of the present invention is to provide a unique system for pulsatilely pumping blood using a biventricular system to compensate for blood volume changes.

A further and no less important object of the present invention is to provide a novel electromagnetic pumping device which is powered by a radioisotope thermoelectric source.

Another significant object of the present invention is to provide an improved artificial heart pump system capable of being implanted within the body,

These and other objects and features of the present invention will become more fully apparent from the following description and appended claims taken in conjunction with the accompanying drawings wherein:

FIG. 1 is a schematic representation of one presently preferred biventricular embodiment of the present inven-- tion; and

FIGS. 2-5 schematically illustrate other presently preferred embodiments of the ventricles illustrated in FIG. 1.

In the presently preferred embodiment of the invention, a biventricular system is illustrated. Although a monoventricular system could be used, the biventricular system is preferred because pulsatile pumping of blood normally requires a way of compensating for blood volume changes within the system. Pulsatile, rather than steady state, blood flow is desirable to enhance capillary perfusion, to prevent visco-elastic creep of the vessels and to operate the physiological baroreceptors.

Reference is now made to FIG. 1 wherein the biventricular artificial heart system generally designated 20 comprises ventricles 22 and 24. Each of the ventricles 22 and 24 is substantially identical to the other, respectively comprising a rigid chamber 26, 27 which is provided with an entrance port 28, 29 and an exit port 30, 31. Each entrance port 28 and 29 is provided with a one-way valve 32 and 33 such as a Gott check valve. Similarly, each exit port 30 and 31 is provided with a one-way valve 34 and 35 which open in a direction opposite the valve 32. Although Gott valves are shown in the illustrated embodiment, clearly any suitable one-way valve, such as a ball check valve could be used. I An accumulator diaphragm or resilient partition 36, 37 is peripherally attached to the interior of the respective ventricles 22 and 24, essentially central thereof, to divide each ventricle into two separate chambers 38, 40 and 39, 41. Each accumulator 36, 37 is preferably made of an inert, flexible material, such as silastic, a commercially available silicone rubber made by Dow-Coming Corporation.

Each entrance port 28, 29 and each exit port 30, 31 have exclusive communication with the respective chambers 38, 39. The chambers 40 and 41 in the ventricles 22 and 24 open into respective upper portions 42 and 44 of a generally U-shaped tube 46. The tube 46, thus, accommodates communication of the respective chambers 40 and 41 in the ventricles 22 and 24.

An electrically conductive fluid 48, such as mercury in the preferred embodiment, is confined, in part, by the tube 46. If desired, a second fluid 50 may be located in the chambers 40 and 41 and the upper portion 42 and 44 of the U-shaped tube above the mercury 48. The fluid 50 is preferably a biologically acceptable fluid, such as, for example, sterile isotonic saline solution. The purpose for the isotonic saline St is to prevent contamination of blood 52 located in chambers 38 and' 39 in the event the accumulator I36 should rupture, develop a puncture or the like. Clearly, the saline solution 50 is merely a safety feature and is not essential to the apparatus or'method comprising the present invention.

The lower portion '54 of the tube 46 carries an electromagnetic pump 56. It is presently preferred that a lightweight, easily portable or man-mobile Faraday type electromagnetic pump be used. In the illustrated embodiment, the mercury 48 is disposed in a thin walled duct 58 within the pump 56. Direct current is passed through a winding on a magnetic core (not shown) comprising part of the pump. The magnetic core is oriented so as to develop a magnetic field having one axis perpendicular to the direction of flow of the mercury 48 as shown by arrows 60 and 62. A voltage is impressed across the mercury 48 in a direction mutually perpendicular to the direction of flow of the mercury and the magnetic field. As a result, the mercury is caused to move axially in the direction of arrows 60 and 62 while the direct ourent is being conducted to the electromagnetic pump 56.

The direct current, needed by the pump 56, is generated by a thermoelectric power source 64. Energy for the thermoelectric power source 64 is preferably derived from radioisotope material such as, for example, promethium 147, made commercially available by Isochem, 'Inc., of Richland, Wash. Promethium 147 has a half-life of 2.62 years and a low energy decay requiring very little shielding and which provides the high current, low voltage output required by the electromagnetic pump. Although promethium 147 is presently preferred, any suitable radioisotope material having a relatively long half-life and low energy decay, including strontium 90, could be used. Moreover, other long-term electrical energy sources, such as chemical power supplies, biological fuel cells, muscle-power generators and the like are within the scope of this invention.

The direct current provided by the thermoelectric source is pulsed by a control device 66 which comprises capacitive elements and a standard conventional pacemaker system for pulsing the direct current to the thermoelectric source.

In the operation of the artificial heart system illustrated in FIG. 1, when the system has been implanted Within a living being, direct current from the power source 64 is pulsed by the control device 66. The resulting pulsatile current is conducted to the electromagnetic driving mechanism 56-. The mercury 48 is then moved in a direction mutually perpendicular to the flows of both the current and the electromagnetic field in the pumping mechanism 56, according to Faradays Law. The accumulators and 41 within the ventricles 22 and 24 are both caused to flex in the direction of flow of the mercury 48. The chamber 38 in ventricle 22 expands to receive blood 52 from the cardiovascular system of the living being, the valve 32 admitting the blood into the chamber 38. The chamber 39 decreases in size and blood 52 is forced out of the chamber 39 through the exit port 31, the valve 35 accommodating one-way movement of the blood out of the ventricle 24. Between pulses the mercury 48 will move in a direction opposite the arows 60 and 62 toward an equilibrium point due to the memory of the elastomeric accumulators 36 and 37 and the force of gravity upon the mercury 48. Movement of the mercury 48 in a direction opposite arrows 60 and 62 will cause the reverse effect, i.e. blood will flow into compartment 39 through the valve 3-3 and out of compartment 38 through the valve 34 until the next pulse is received by the pump 56. v

Alternatively, the same pump or an adjacent substantially substantially identical pump could be used to forcibly 4- move the mercury 48 in the opposite direction, thereby cyclically forcing the mercury 48 alternately toward the ventricles 24 and 22. The interval of alternation would be determined by the pacemaker (not shown) within the control device. 66.

If desired, the ventricle illustrated in FIG. 2 can be used in place of the ventricles 22 or 24 illustrated in FIG. 1. With reference to FIG. 2, a cylindrically-shaped rigid element 70- is provided with an inlet port 72 and an outlet port 74. Each of the ports 72 and 74 is provided with one-way valves 32 and 34 which are substantially identical to valves 32 and 34 in FIG. 1. Inlet port 72 and outlet port 74 are connected by tube 76 sealed in fluid-tight relation at the ends 78 and 80 to the interior surface 82 of the element 70. The fluid 50, moved by the mercury 48 as described in FIG. 1, causes the tube 76 to collapse and squeezes the blood 52 contained therein through the outlet port 74. When the tube 76 returns to its normal cylindrical configuration, blood 52 is allowed to pass through the inlet port 72 into the tube 76.

FIG. 3 illustrates another preferred embodiment of a ventricle which may be used in place of the ventricles 22 and 24 of FIG. 1. In the embodiment of FIG. 3, inlet port 86 and outlet port 88 are disposed in a substantially flat element 90. A bell-shaped member 92 cooperates with the element to form a rigid ventricle. An accumulator 94 is peripherally attached at 95 between the element 90 and the member 92 in fluid-sealed relation, thus forming two separate accumulator chambers 96 and 98. The accumulator chamber 98 is in free communication with fluid 50 through the tube 97. When the fluid is forced into the chamber 98, the accumulator 9'4 collapses forcing blood'52 out through the outlet port 88. When fluid 50 is withdrawn from the chamber 98, the chamber 96 is filled with blood through the inlet port 86.

FIG. 4 illustrates still another embodiment of a ventricle which may be used in place of the ventricles 22 and 24 illustrated in FIG. 1. With reference to FIG. 4, inlet port 100 and outlet port 102 are disposed in the essentially bell-shaped member 104. The bell-shaped member 104 cooperates with an essentially flat element 106 to form a rigid ventricle. The ventricle is internally provided with an accumulator 108 which is fluid-sealed at the periphery 110 between the member 104 and the element 106. The acumulator108 forms accumulator chambers 112 and 114. When accumulator chamber 114 expands due to the influx of fluid 50 through the tube 116, blood 52 is forced out of the outlet port 102 and, conversely, when the accumulator chamber 114 decreases in size due to the egress of fluid 50 through the tube 116, blood will enter the accumulator chamber 112 through the inlet port 100.

FIG. 5 schematically illustrates a differential piston pump which may be used in place of the ventricles 22 and 24 of FIG. 1. In FIG. 5, a rigid casing is provided with outlet port 122 and inlet port 124. A rolling diaphragm 126 is fluid-sealed at one end 128 to the casing 120 and, likewise, fluid-sealed at the other end 130 toa differential piston 132. The trailing end of the piston is in contact with a high-pressure rolling diaphragm 136 fluid-sealed at the exterior of the casing 120. The diaphragm 136 forms a chamber 138 with a fluidcarrying coupling 140 which is continuous with tube 142.

Fluid 50 entering the chamber 138 through the tube 142 forces the piston 132 to advance toward'the inlet and outlet ports 124 and 122, respectively. As the differential piston 132 moves, the rolling diaphragm 126 rolls upon itself and blood 52 is forced out through the outlet port 122. Conversely, when fluid 1'50 egresses through tube 142, the differential piston 132 will move in the opposite direction causing the diaphragm 136 to roll upon itself and blood will move through the inlet port 124.

It should now be appreciated that the present invention provides a new and useful apparatus and technique for pumping blood in connection with or in place of the heart of a living being. Electromagnetic pumping of a conducting fluid other than blood reduces heat generation in the blood and substantially eliminates electrolysis thereof. The provision of a long-life radioisotope energy source used in connection with a lightweight thermoelectric generator makes implantation of the artificial heart system within the body of the living being practical.

The invention may be embodied in other specific forms without departing from the spirit or essential characteristics thereof. The present embodiments are, therefore, to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore to be embraced therein.

What is claimed and desired to be secured by United States Letters Patent is:

1. An artificial heart pump apparatus comprising electrically conductive fluid other than blood and ventricle means having accumulator means disposed therein responsive to pulsatile displacement of the electrically conductive fluid, the accumulator means comprising at least one resilient partition defining two chambers the peripheral edge of the partition being joined to the ventricle means in fluid tight relation, one chamber and one surface of the partition adapted to be disposed in pressure communication and contact with circulated blood obtainable from the cardiovascular system of a living body, the

other chamber and a second opposed surface of the partition being in pressure communication with the electrically-conductive fluid, electromagnetic means for exposing said electrically-conductive fluid to a magnetic field caused by the electromagnetic means to exert a pulsating force on and cyclically displace the electricallyconductive fluid thereby causing the conductive fluid to cyclically exert pressure upon the second surface of the partition in the other chamber, and ingress and egress valve means adapted to be placed in fluid communication with the cardiovascular system for successively receiving and emitting substantially equal volumes of blood to and from the one chamber of the ventricle means in response to back and forth displacement of the partition.

2. In an apparatus as defined in claim 1 wherein said ventricle means comprise interconnected biventricular structure, the two parts of said biventricular structure being in simultaneous communication one with the other linked by the electrically-conductive fluid, each of the two parts of the biventricular structure being provided with separate accumulator structure each defining the two chambers, adapted to serially exert increased pressure on the blood to respectively simultaneously expel and draw equal volumes of blood from and to the one chambers of the accumulator structure, thereby maintaining a uniform blood level for use within the cardiovascular system.

3. An artificial heart pump comprising in combination: thermoelectric power source means for generating electrical energy, means for pulsing the flow of electrical energy from the source means, confined electrically conductive fluid, electromagnetic driving means responsive to the pulsed flow of electrical energy for pulsatilely pumping the confined electrically-conductive fluid by magnetic energy without the use of mechanically moving parts, dual ventricles each comprising accumulator means adapted to separate blood on one side from at least one other fluid subject to pressure caused by the action of the electrical energy confined within fluid communication means and disposed on the other side of the accumulator means, said accumulator means responding to changes in pressure exerted by the confined electrically-conductive fluid when influenced by electrical energy, and one-way valve means for selectively controlling the flow of the blood in and out of the ventricles.

4. In a heart pump as defined in claim 3 where in the thermoelectric power source means comprises a manmobile, long-term radioisotope thermoelectric power source.

5. In a heart pump as defined in claim 3 further con1- prising an isotonic, biologically compatible liquid interposed between the electromagnetic driving means and the accumulator means.

6. In a method of pumping blood within a living body by cyclically exposing an electrically-conductive fluid to an electromagnetic field, thereby pulsing the electricallyconductive fluid which is in pressure-communication with one side of a deformable accumulator partition of sheet material, flexing the central interior of the sheet accumulator partition in response to the pulsatile pressure exerted by the electrically-conductive fluid, imposing the pulsatile pressure on the blood across the sheet partition which blood is in communication with the other side of the deformable sheet accumulator partition and displacing the blood in response to the fluid pressure in a direction pre-defined by check valves.

7. A method of pumping blood through a ventricular artificial heart apparatus used by a living body comprising the steps of: providing a source of electrical current, pulsatilely exposing electrically conductive liquid to the electrical current to pulsatilely pump the electrically conductive liquid to impose a series of pressure pulses upon one side of an accumulator diaphragm comprising part of the artificial heart apparatus, flexing the accumulator diaphragm responsive to the pressure pulses of the electrically-conductive liquid, and cyclically receiving and emitting blood adjacent the other side of the accumulator diaphragm, maintaining an essentially constant uniform blood volume within the cardiovascular system of the living body according to the motion of the flexing accumulator.

8. A method as defined in claim 7 wherein the pulsatilely exposing step is responsive to a conversion of ther-' mal energy emitted by a radioisotope source to electrical energy.

References Cited UNITED STATES PATENTS 2,812,716 11/1957 Gray 103-44X(D) 3,007,416 11/ 1961 Childs 10344 (D) 3,277,827 10/ 1966 Roes 1031(M) 3,379,191 4/1968 Harvey 31X OTHER REFERENCES Air-Driven Artificial Hearts Inside The Chest, by W. Seidel et al. transactions of the American Society of Artificial Internal Organs, vol. VII, 1961, pp. 378-385.

Prolonged Mechanical Circulatory Support: Analysis of Certain Physical and Physiologic Considerations, by E. Bernstein et al., Surgery, vol. 57, No. 1, pp. 103-122.

RICHARD A GAUDET, Primary Examiner R. L. FRINKS, Assistant Examiner U.S.Cl.X.R.

Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3807446 *Jun 5, 1972Apr 30, 1974Battelle Development CorpRespirator system
US3831203 *Sep 28, 1973Aug 27, 1974Atomic Energy CommissionImplantable blood pumping system
US3874002 *Sep 7, 1972Apr 1, 1975Kurpanek W HPulsatile magneto-motive artificial heart
US3916449 *Nov 19, 1974Nov 4, 1975Pacific Roller Die Co IncImplantable heart pump
US3923426 *Aug 15, 1974Dec 2, 1975Alza CorpElectroosmotic pump and fluid dispenser including same
US4083786 *Mar 10, 1976Apr 11, 1978Asahi Kasei Kogyo Kabushiki KaishaApparatus for treating ascites
US4144595 *Nov 18, 1976Mar 20, 1979Felix UngerArtificial heart chamber
US4152786 *Dec 12, 1977May 8, 1979Andros IncorporatedCompensator for implanted blood pump
US4173796 *Dec 9, 1977Nov 13, 1979University Of UtahTotal artificial hearts and cardiac assist devices powered and controlled by reversible electrohydraulic energy converters
US4369530 *May 19, 1981Jan 25, 1983Foxcroft AssociatesHydraulically actuated cardiac prosthesis and method of actuation
US4376312 *May 19, 1981Mar 15, 1983Foxcroft AssociatesHydraulically actuated cardiac prosthesis
US4381567 *Sep 15, 1981May 3, 1983Foxcroft AssociatesHydraulically actuated total cardiac prosthesis with reversible pump and three-way ventricular valving
US4389737 *Sep 15, 1981Jun 28, 1983Foxcroft AssociatesHydraulically actuated cardiac prosthesis with three-way ventricular valving
US4397049 *Sep 15, 1981Aug 9, 1983Foxcroft AssociatesHydraulically actuated cardiac prosthesis with three-way ventricular valving
US4417861 *Dec 24, 1981Nov 29, 1983Monsanto CompanyCell culture pumping system
US4458366 *Aug 6, 1982Jul 10, 1984Macgregor David CArtificial implantable blood pump
US4493314 *Jun 30, 1982Jan 15, 1985Lundell Laboratories, Inc.Heart pump
US4524466 *Nov 30, 1983Jun 25, 1985Southwest Research InstituteContinuous rotation reversible pitch axial thrust heart pump
US4547911 *Dec 2, 1983Oct 22, 1985Strimling Walter EImplantable heart pump
US4566291 *Oct 15, 1984Jan 28, 1986General Pneumatics CorporationClosed cycle cryogenic cooling apparatus
US4627419 *Aug 29, 1984Dec 9, 1986The Board Of Regents, The University Of TexasBlood pump apparatus and method
US4731076 *Dec 22, 1986Mar 15, 1988Baylor College Of MedicinePiezoelectric fluid pumping system for use in the human body
US4820300 *Jun 1, 1987Apr 11, 1989Research Corporation Technologies, Inc.Artificial heart
US4863461 *Mar 21, 1988Sep 5, 1989Symbion, Inc.Artificial ventricle
US4976729 *Aug 15, 1988Dec 11, 1990University Of Utah Research FoundationElliptical artificial heart
US5089017 *Jan 17, 1989Feb 18, 1992Young David BDrive system for artificial hearts and left-ventricular assist devices
US5139517 *Jul 26, 1991Aug 18, 1992Corral David FOrthotopic intraventricular heart pump
US5282849 *Dec 19, 1991Feb 1, 1994University Of Utah Research FoundationVentricle assist device with volume displacement chamber
US5685698 *Jul 30, 1996Nov 11, 1997Smoll; Owen ClarkMethod and apparatus for a pulsatile blood pump with no hemolysis
US6251061 *Sep 9, 1998Jun 26, 2001Scimed Life Systems, Inc.Cardiac assist device using field controlled fluid
US6406422Mar 2, 2000Jun 18, 2002Levram Medical Devices, Ltd.Ventricular-assist method and apparatus
US6440059 *Oct 14, 1999Aug 27, 2002Cimex Biotech LcMagnetohydrodynamic cardiac assist device
US7066874 *Jan 6, 2004Jun 27, 2006Bay Innovation Group, LlcDevices and methods for blood flow assistance
US7303581Sep 2, 2005Dec 4, 2007Peralta Eduardo JArtificial heart using magnetohydrodynamic propulsionh
US8372145Aug 28, 2009Feb 12, 2013Hisham M. F. SHERIFImplantable artificial ventricle having low energy requirement
US8556225 *Jul 30, 2010Oct 15, 2013Deka Products Limited PartnershipPump chamber configured to contain a residual fluid volume for inhibiting the pumping of a gas
US8834343Apr 3, 2009Sep 16, 2014Deutsches Zentrum Fur Luft-UndHeart support device
US8863772Aug 27, 2008Oct 21, 2014Deka Products Limited PartnershipOccluder for a medical infusion system
US9028440Jan 23, 2009May 12, 2015Deka Products Limited PartnershipFluid flow occluder and methods of use for medical treatment systems
US9039395Jun 2, 2014May 26, 2015Deka Products Limited PartnershipSystem, method, and apparatus for utilizing a pumping cassette
US9222472May 29, 2014Dec 29, 2015Deka Products Limited PartnershipSystem, method, and apparatus for utilizing a pumping cassette
US9358332Jan 23, 2009Jun 7, 2016Deka Products Limited PartnershipPump cassette and methods for use in medical treatment system using a plurality of fluid lines
US9364655May 24, 2012Jun 14, 2016Deka Products Limited PartnershipFlexible tubing occlusion assembly
US9488167May 29, 2014Nov 8, 2016Deka Products Limited PartnershipSystem, method, and apparatus for utilizing a pumping cassette
US9494150Aug 22, 2013Nov 15, 2016Deka Products Limited PartnershipPump chamber configured to contain a residual fluid volume for inhibiting the pumping of a gas
US9494151Jun 2, 2014Nov 15, 2016Deka Products Limited PartnershipSystem, method, and apparatus for utilizing a pumping cassette
US9593678May 29, 2014Mar 14, 2017Deka Products Limited PartnershipSystem, method, and apparatus for utilizing a pumping cassette
US20050148810 *Jan 6, 2004Jul 7, 2005Riebman Jerome B.Devices and methods for blood flow assistance
US20060058873 *Sep 2, 2005Mar 16, 2006Peralta Eduardo JArtificial heart using magnetohydrodynamic propulsionh
US20100057016 *Aug 27, 2008Mar 4, 2010Deka Products Limited PartnershipOccluder for a medical infusion system
US20100296953 *Jul 30, 2010Nov 25, 2010Deka Products Limited PartnershipPump chamber configured to contain a residual fluid volume for inhibiting the pumping of a gas
US20110092894 *Jan 23, 2009Apr 21, 2011Deka Research & DevelopmentPump cassette and methods for use in medical treatment system using a plurality of fluid lines
US20110098635 *Jan 23, 2009Apr 28, 2011Deka Research & DevelopmentFluid flow occluder and methods of use for medical treatment systems
US20110137107 *Apr 3, 2009Jun 9, 2011Bernhard VodermayerHeart support device
US20110223581 *Dec 18, 2009Sep 15, 2011Stobbe Tech A/SElectronically controlled diaphragm pump
USRE31040 *Feb 15, 1980Sep 28, 1982St. Jude Medical, Inc.Heart valve prosthesis
CN104254352A *Feb 16, 2012Dec 31, 2014宽塔流体解决方案有限公司血泵
CN104254352B *Feb 16, 2012Dec 14, 2016宽塔流体解决方案有限公司血泵
DE3408331A1 *Mar 7, 1984Sep 12, 1985Fresenius AgPumpanordnung fuer medizinische zwecke
EP3120881A1 *Jul 23, 2015Jan 25, 2017Northern Development ASPulsatile ventricular assist device
WO1982003980A1 *May 12, 1982Nov 25, 1982Foxcroft AssociatesHydraulically actuated cardiac prosthesis
WO1984003139A1 *Jan 31, 1984Aug 16, 1984Gen Pneumatics CorpClosed cycle cryogenic cooling apparatus
WO1985002339A1 *Nov 15, 1984Jun 6, 1985Strimling Walter WImplantable heart pump
WO2009121962A1 *Apr 3, 2009Oct 8, 2009Deutsches Zentrum für Luft- und Raumfahrt e. V.Heart support device
U.S. Classification623/3.21, 417/411, 600/16, 604/113, 604/6.11, 417/389, 417/395
International ClassificationF04B43/00, F04B43/10, F04B43/06, F04B43/09, F04B43/02, A61M1/10
Cooperative ClassificationF04B43/10, F04B43/026, A61M1/106, F04B43/09, F04B43/06
European ClassificationA61M1/10E4H, F04B43/06, F04B43/02P3, F04B43/10, F04B43/09